Comparative Pharmacology
Head-to-head clinical analysis: DIFFERIN versus RENOVA.
Peer-Reviewed Evidence
Head-to-head clinical analysis: DIFFERIN versus RENOVA.
DIFFERIN vs RENOVA
Comparing the clinical profiles, pharmacokinetic behaviors, and safety indices of these two therapeutic agents.
Adapalene is a retinoid-like compound that binds to retinoic acid receptors (RARs) and retinoid X receptors (RXRs), modulating gene expression and normalizing differentiation and proliferation of follicular epithelial cells, reducing comedogenesis and inflammation.
Renova (tretinoin) is a retinoid that binds to retinoic acid receptors (RARα, RARβ, RARγ) and retinoid X receptors (RXRα, RXRβ, RXRγ). It modulates gene expression, increasing collagen synthesis, reducing collagen breakdown via inhibition of matrix metalloproteinases, and promoting epidermal cell turnover and proliferation.
Apply a thin layer of 0.1% gel or cream to affected areas once daily in the evening.
Apply a thin layer to affected area once daily at bedtime. Use only fingertips to apply (0.1% cream).
None Documented
None Documented
Terminal elimination half-life is approximately 14–22 hours; steady-state is achieved within 3–5 days.
Terminal half-life is 2-4 hours in patients with normal renal function; prolonged to 18-24 hours in end-stage renal disease
Primarily biliary/fecal (>95%) as unchanged drug and metabolites; renal excretion is negligible.
Renal (approximately 99% as unchanged drug), biliary/fecal (<1%)
Category C
Category C
Topical Retinoid
Topical Retinoid